{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:52Z","timestamp":1783468852433,"version":"3.55.0"},"reference-count":24,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T00:00:00Z","timestamp":1585958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Cachexia is an unfavorable metabolic syndrome causing involuntary weight loss followed by muscle wasting, which can lead to the exacerbation of chronic heart failure (CHF), and considerably increases mortality rate among CHF patients. Unfortunately, until now it has not been possible to determine factors that could improve clinical options for cachexia management or enable the identification of patients at risk of its development. We assessed how cachexia conditions in CHF reflect cardiac and laboratory parameters in comparison with non-cachectic patients. Methods: 66 women were enrolled to the study group and underwent meticulous screening, according to recent clinical guidelines, in order to enable CHF and cachexia detection. Body composition was evaluated by bioelectrical impedance analysis (BIA) and laboratory tests were supplemented by analysis of plasma circulating irisin. Results: A negative correlation between irisin concentration and both CRP and TNF-\u03b1 was recorded (R = \u22120.362 and R = \u22120.243; p &lt; 0.05). Irisin concentration positively correlated with EF% (R = 0.253; p = 0.046) and negatively with LVESd, LVEDd and NT-proBNP (R = \u22120.326, \u22120.272, and \u22120.320; p &lt; 0.05). Both low levels of circulating irisin and Capacitance of membrane (Cm) were selected as unfavorable factors affecting cachexia in CHF patients (OR = 1.39 and 34.49; p &lt; 0.05). Combination of Cm, irisin, CRP and albumin demonstrated sensitivity of 93.3% and specificity of 85.3% (AUC = 0.949) for distinguishing between cachectic and non-cachectic CHF patients. Conclusions: Selected parameters reliably reflect cachectic conditions in CHF, and the proposed approach for cachexia based on the combined analysis of at least a few non-invasive markers could offer new opportunities for improving clinical outcomes in CHF patients.<\/jats:p>","DOI":"10.3390\/jcm9041021","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T03:58:39Z","timestamp":1586231919000},"page":"1021","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Electrical and Hormonal Biomarkers in Cachectic Elderly Women with Chronic Heart Failure"],"prefix":"10.3390","volume":"9","author":[{"given":"Grzegorz","family":"Sobieszek","sequence":"first","affiliation":[{"name":"Department of Cardiology, 1st Military Clinical Hospital with the Outpatient Clinic, 20-048 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Powr\u00f3zek","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Mazurek","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Skwarek-Dziekanowska","sequence":"additional","affiliation":[{"name":"Department of Cardiology, 1st Military Clinical Hospital with the Outpatient Clinic, 20-048 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Ma\u0142ecka-Massalska","sequence":"additional","affiliation":[{"name":"Department of Human Physiology, Medical University of Lublin, 20-080 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,4,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Sobieszek, G., Mlak, R., Skwarek-Dziekanowska, A., Jurzak-My\u015bliwy, A., Homa-Mlak, I., and Ma\u0142ecka-Massalska, T. (2019). Electrical Changes in Polish Patients with Chronic Heart Failure: Preliminary Observations. Medicina, 55.","DOI":"10.3390\/medicina55080484"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4065\/mcp.2009.0494","article-title":"Chronic Heart Failure: Contemporary Diagnosis and Management","volume":"85","author":"Ramani","year":"2010","journal-title":"Mayo Clin. Proc."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"G\u0159iva, M. (2016). Cardiac cachexia-Up-to-date 2015. Cor Vasa, 58.","DOI":"10.1016\/j.crvasa.2015.08.003"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Okoshi, M.P., Capalbo, R.V., Romeiro, F.G., and Okoshi, K. (2016). Cardiac Cachexia: Perspectives for Prevention and Treatment. Arq. Bras. Cardiol.","DOI":"10.5935\/abc.20160142"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Kalkan, A.K., Cakmak, H.A., Erturk, M., Kalkan, K.U., Uzun, F., Tasbulak, O., Diker, V.O., Aydin, S., and Celik, A. (2018). Adropin and Irisin in Patients with Cardiac Cachexia. Arq. Bras. Cardiol.","DOI":"10.5935\/abc.20180109"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Aydin, S., and Aydin, S. (2016). Irisin Concentrations as a Myocardial Biomarker. Biomark. Cardiovasc. Dis., 489\u2013504.","DOI":"10.1007\/978-94-007-7678-4_3"},{"key":"ref_7","first-page":"30","article-title":"The role of irisin in ischemic heart diesease","volume":"9","author":"Korabiusz","year":"2019","journal-title":"J. Educ. Health Sport"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Silvestrini, A., Bruno, C., Vergani, E., Venuti, A., Favuzzi, A.M.R., Guidi, F., Nicolotti, N., Meucci, E., Mordente, A., and Mancini, A. (2019). Circulating irisin levels in heart failure with preserved or reduced ejection fraction: A pilot study. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210320"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1139\/cjpp-2018-0736","article-title":"Serum irisin level in myocardial infarction patients with or without heart failure","volume":"97","author":"Galal","year":"2019","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"10895","DOI":"10.3390\/s140610895","article-title":"The Theory and Fundamentals of Bioimpedance Analysis in Clinical Status Monitoring and Diagnosis of Diseases","volume":"14","author":"Khalil","year":"2014","journal-title":"Sensors"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/ejcn.2015.126","article-title":"The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients\u2014A comprehensive review","volume":"69","author":"Grundmann","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.ajem.2015.04.021","article-title":"Bioelectrical impedance analysis for heart failure diagnosis in the ED","volume":"33","author":"Mewton","year":"2015","journal-title":"Am. J. Emerg. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_14","unstructured":"The Criteria Committee of the New York Heart Association (1994). Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, Little, Brown & Co.. [9th ed.]."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: A new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin. Nutr."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2017.11.072","article-title":"Serum irisin levels are associated with adverse cardiovascular outcomes in patients with acute myocardial infarction","volume":"261","author":"Hsieh","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Okoshi, M.P., Romeiro, F.G., Paiva, S.A.R., and Okoshi, K. (2013). Heart Failure-Induced Cachexia. Arq. Bras. Cardiol.","DOI":"10.5935\/abc.20130060"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1002\/ejhf.1304","article-title":"Comparison of sarcopenia and cachexia in men with chronic heart failure: Results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF)","volume":"20","author":"Emami","year":"2018","journal-title":"Eur. J. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1227\/NEU.0000000000000369","article-title":"MicroRNAs as biomarkers in pituitary tumors","volume":"75","author":"Butz","year":"2014","journal-title":"Neurosurgery"},{"key":"ref_21","first-page":"1555","article-title":"Prognostic impact of sarcopenia and its correlation with circulating miR-21 in colorectal cancer patients","volume":"39","author":"Okugawa","year":"2018","journal-title":"Oncol. Rep."},{"key":"ref_22","unstructured":"Experientia, S., and Igaz, P. (2015). Circulating microRNAs as Biomarkers in Cardiovascular Diseases. Circulating microRNAs in Disease Diagnostics and Their Potential Biological Relevance, Springer."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jcsm.12495","article-title":"Effects of aerobic and inspiratory training on skeletal muscle microRNA-1 and downstream-associated pathways in patients with heart failure","volume":"11","author":"Trevizan","year":"2020","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/ejhf.1119","article-title":"Transcoronary concentration gradients of circulating microRNAs in heart failure","volume":"20","author":"Eposito","year":"2018","journal-title":"Eur. J. Heart Fail."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/4\/1021\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:15:33Z","timestamp":1760174133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/9\/4\/1021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,4]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["jcm9041021"],"URL":"https:\/\/doi.org\/10.3390\/jcm9041021","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,4]]}}}